Literature DB >> 10813186

Autologous morsellised bone grafting restores uncontained femoral bone defects in knee arthroplasty. An in vivo study in horses.

C J van Loon1, M C de Waal Malefijt, P Buma, T Stolk, N Verdonschot, A M Tromp, R Huiskes, A Barneveld.   

Abstract

The properties of impacted morsellised bone graft (MBG) in revision total knee arthroplasty (TKA) were studied in 12 horses. The left hind metatarsophalangeal joint was replaced by a human TKA. The horses were then randomly divided into graft and control groups. In the graft group, a unicondylar, lateral uncontained defect was created in the third metatarsal bone and reconstructed using autologous MBG before cementing the TKA. In the control group, a cemented TKA was implanted without the bone resection and grafting procedure. After four to eight months, the animals were killed and a biomechanical loading test was performed with a cyclic load equivalent to the horse's body-weight to study mechanical stability. After removal of the prosthesis, the distal third metatarsal bone was studied radiologically, histologically and by quantitative and micro CT. Biomechanical testing showed that the differences in deformation between the graft and the control condyles were not significant for either elastic or time-dependent deformations. The differences in bone mineral density (BMD) between the graft and the control condyles were not significant. The BMD of the MBG was significantly lower than that in the other regions in the same limb. Micro CT showed a significant difference in the degree of anisotropy between the graft and host bone, even although the structure of the area of the MBG had trabecular orientation in the direction of the axial load. Histological analysis revealed that all the grafts were revascularised and completely incorporated into a new trabecular structure with few or no remnants of graft. Our study provides a basis for the clinical application of this technique with MBG in revision TKA.

Entities:  

Mesh:

Year:  2000        PMID: 10813186     DOI: 10.1302/0301-620x.82b3.9491

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  7 in total

1.  Tissue engineering applications in the management of bone loss.

Authors:  Christian Carulli; Fabrizio Matassi; Roberto Civinini; Massimo Innocenti
Journal:  Clin Cases Miner Bone Metab       Date:  2013-01

2.  The efficacy of porous hydroxyapatite bone chip as an extender of local bone graft in posterior lumbar interbody fusion.

Authors:  Hyoungmin Kim; Choon-Ki Lee; Jin-Sup Yeom; Jae-Hyup Lee; Ki-Ho Lee; Bong-Soon Chang
Journal:  Eur Spine J       Date:  2011-12-03       Impact factor: 3.134

3.  A sliding stem in revision total knee arthroplasty provides stability and reduces stress shielding.

Authors:  Huub J Meijerink; Corné J M van Loon; Maarten C de Waal Malefijt; Albert van Kampen; Nico Verdonschot
Journal:  Acta Orthop       Date:  2010-06       Impact factor: 3.717

4.  Reliable landmarks for precise topographical analyses of pathological structural changes of the ovine tibial plateau in 2-D and 3-D subspaces.

Authors:  Tamás Oláh; Jan Reinhard; Liang Gao; Lars K H Goebel; Henning Madry
Journal:  Sci Rep       Date:  2018-01-08       Impact factor: 4.379

Review 5.  ACETABULAR RECONSTRUCTION IN PAPROSKY TYPE III DEFECTS.

Authors:  Jaime J Morales De Cano; Llorenç Guillamet; Arturo Perez Pons
Journal:  Acta Ortop Bras       Date:  2019 Jan-Feb       Impact factor: 0.513

6.  Is an impacted morselized graft in a cage an alternative for reconstructing segmental diaphyseal defects?

Authors:  Pieter H J Bullens; H W Bart Schreuder; Maarten C de Waal Malefijt; Nico Verdonschot; Pieter Buma
Journal:  Clin Orthop Relat Res       Date:  2009-01-14       Impact factor: 4.176

7.  Effect of age on bone mineral density and micro architecture in the radius and tibia of horses: an Xtreme computed tomographic study.

Authors:  A Fürst; D Meier; S Michel; A Schmidlin; L Held; A Laib
Journal:  BMC Vet Res       Date:  2008-01-25       Impact factor: 2.741

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.